Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

J&J to Restore Full Access to Doxil Cancer Drug
FOX Business
Tuesday, October 16, 2012 - 10:50am
tags:
JNJ, Doxil, cancer, drug shortages
Roche Still Seeks Sequencing Expansion After Illumina
Bloomberg
Tuesday, October 16, 2012 - 10:48am
tags:
Roche, Illumina, gene sequencing
India Pushes To End Sale Of Branded Drugs
Pharmalot
Tuesday, October 16, 2012 - 10:46am
tags:
India, generics
Amedisys drops 9% on Humana revenue cuts
Marketwatch
Tuesday, October 16, 2012 - 10:45am
tags:
Humana, Amedisys, home healthcare
Gilead shares should advance on upcoming data, says RBC Capital
The Fly on the Wall
Tuesday, October 16, 2012 - 10:43am
tags:
Gilead, hepatitis C
Another Reason To Be Long AbbVie When Abbott Splits In Two
Seeking Alpha
Tuesday, October 16, 2012 - 10:42am
tags:
AbbVie, Abbott Labs, ABT-450
Lexicon Pharma: Blockbuster Potential From A Diabetes Drug
TheStreet.com
Tuesday, October 16, 2012 - 10:40am
tags:
diabetes, Lexicon Pharmaceuticals, LX4211, sodium-dependent glucose transporter
3 Things to Watch at Ariad Pharmaceuticals
Motley Fool
Tuesday, October 16, 2012 - 10:38am
tags:
Ariad Pharmaceuticals, Ponatinib, ridaforolimus, AP1903, AP26113
Abbott Labs Pops to New All-Time High After Clinical Results
Wall St. Cheat Sheet
Tuesday, October 16, 2012 - 10:37am
tags:
Abbott Labs, hepatitis C
J&J’s Third-Quarter Profit Beats Estimates on Drug Sales
Bloomberg
Tuesday, October 16, 2012 - 9:25am
tags:
earnings, JNJ
AstraZeneca Expands R&D in China to Boost Drug Discovery
Bloomberg
Monday, October 15, 2012 - 11:44am
tags:
R&D, China, AstraZeneca
Prima BioMed announces interim data from CAN-003 trial
Yahoo/Fly on the Wall
Monday, October 15, 2012 - 11:43am
tags:
Prima BioMed, CAN-003, ovarian cancer
Kidney Week Should Prove Beneficial For Questcor's Acthar
Seeking Alpha
Monday, October 15, 2012 - 11:42am
tags:
Questcor, Acthar
Dendreon and Celgene Cancer Treatment Catalysts Face Rocky Road
Wall St. Cheat Sheet
Monday, October 15, 2012 - 11:41am
tags:
Celgene, Dendron, Provenge, prostate cancer
Merck gets rights to HCMV drug from Bayer spin-off AiCuris
Pharma Times, UK
Monday, October 15, 2012 - 11:40am
tags:
Merck, Bayer, AiCuris, HCMV, letermovir
Lilly's ImClone Purchase Pays Off
Forbes
Monday, October 15, 2012 - 11:38am
tags:
Eli Lilly, ImClone, ramucirumab
Bristol-Myers Trails U.S. Rivals as Promising Drugs Fade
Bloomberg
Monday, October 15, 2012 - 11:38am
tags:
Bristol-Myers Squibb
Abbott Hep C Therapy Achieves Almost-Perfect Cure Rate
TheStreet.com
Monday, October 15, 2012 - 11:37am
tags:
Abbott Labs, hepatitis C, ABT-450, ABT-267, ABT-333, Gilead
FDA panel says lomitapide data supports 'appropriate use'
Yahoo/Fly on the Wall
Monday, October 15, 2012 - 11:11am
tags:
FDA, lomitapide, advisory panels, HoFH, Homozygous Familial Hypercholesterolemia, Aegerion
Forbes Earnings Preview: Abbott Laboratories
Forbes
Monday, October 15, 2012 - 10:43am
tags:
earnings, Abbott Labs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.